Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/SYNACT stock hub

STO/SYNACT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/SYNACTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

780.7M

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/SYNACT

In the news

Latest news · STO/SYNACT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.7

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-57.7

P25 n/aP50 n/aP75 n/a

ROIC-37.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/SYNACT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

148

Groups with data

Currency

SEK

Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	8
Employees Change	3%
Employees Change Percent	60
Enterprise value	SEK 728.5M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0008241491
Last refreshed	2026-05-10
Market cap	SEK 780.7M
Price	SEK 13.94
Price currency	SEK
Sector	Healthcare
Sic	2836
Symbol	sto/SYNACT
Website	https://synactpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.2%
EV Earnings	-6.57x
Forward P/E	13.67x
P/B ratio	4.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	SEK -110.8M
Net Income Growth Years	0%
Profit Per Employee	SEK -13.9M
ROA	-29.6
Roa5y	-67.03
ROCE	-58.44
ROE	-57.65
Roe5y	-150.9
ROIC	-37.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.26%
Cagr3y	-43.1%
Cagr5y	-30.45%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	SEK 220.5M
Cash	SEK 53.4M
Current Assets	SEK 71.3M
Current Liabilities	SEK 21.5M
Debt	SEK 1.2M
Debt Equity	SEK 0.01
Equity	SEK 170.3M
Interest Coverage	-128.9
Liabilities	SEK 50.2M
Long Term Assets	SEK 149.2M
Long Term Liabilities	SEK 28.7M
Net Cash	SEK 52.2M
Net Cash By Market Cap	SEK 6.69
Net Cash Growth	-12.02%
Net Debt Equity	SEK -0.31
Tangible Book Value	SEK 170.3M
Tangible Book Value Per Share	SEK 3.19
WACC	9.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.31
Net Working Capital	SEK -3M
Quick ratio	3.1
Working Capital	SEK 49.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-28.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.24%
200-day SMA	20.1
3Y total return	-81.59%
50-day SMA	17.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-83.72%
All Time High	146
All Time High Change	-90.45%
All Time High Date	2021-12-03
All Time Low	4.75
All Time Low Change	193.47%
All Time Low Date	2016-07-18
ATR	0.95
Beta	0.88
Beta1y	0.27
Beta2y	0.33
Ch YTD	-38.32
High	15.3
High52	25.3
High52 Date	2025-10-10
High52ch	-44.9%
Low	13.8
Low52	13.4
Low52 Date	2025-05-30
Low52ch	4.03%
Ma50ch	-20.79%
Price vs 200-day SMA	-30.66%
RSI	26.06
RSI Monthly	42.08
RSI Weekly	34.81
Sharpe ratio	-0.61x
Sortino ratio	-0.78
Total Return	-28.94%
Tr YTD	-38.32
Tr1m	-22.12%
Tr1w	-18%
Tr3m	-35.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -116.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32,304,712%
Net Borrowing	-576,000
Shares Insiders	14.03%
Shares Institutions	18.29%
Shares Out	56,001,661
Shares Qo Q	0.8%
Shares Yo Y	28.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	260,108.05x
Bv Per Share	3.19
Ch1m	-22.12
Ch1w	-18
Ch1y	-29.24
Ch3m	-35.76
Ch3y	-81.75
Ch5y	-83.96
Ch6m	-36.35
Change	-7.31%
Change From Open	-8.29
Close	15.04
Days Gap	1.06
Depreciation Amortization	13,000
Dollar Volume	5,549,918.3
Earnings Date	2026-04-15
EBIT	SEK -116.3M
EBITDA	SEK -116.3M
EPS	SEK -2.17
F Score	2
Financing CF	90,458,000
Fiscal Year End	December
Founded	2,012
Income Tax	SEK -8.2M
Is Primary Listing	1
Last Earnings Date	2026-04-15
Last Report Date	2025-12-31
Ma150	20.3
Ma150ch	-31.33%
Ma20	17.01
Ma20ch	-18.06%
Net CF	-7,803,000
Next Earnings Date	2026-05-27
Open	15.2
Position In Range	9.33
Ppne	1,214,000
Price Date	2026-05-08
Ptbv Ratio	4.58
Relative Volume	1.61x
Share Based Comp	1,888,000
Tr6m	-36.35%
Volume	398,129

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/SYNACT pay a dividend?

Capital-return profile for this ticker.

Performance

STO/SYNACT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/SYNACT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.3%

Share of float held by funds and institutions

Insider ownership

+14.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+28.9%

Negative means the company is buying back shares.

Technical

STO/SYNACT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

26.1

Below 30: short-term oversold

Price vs 200-day MA

-30.7%

50/200-day relationship not available

Beta (5Y)

0.88

Moves roughly with the market

Sharpe ratio

-0.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/SYNACT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/SYNACT stock rating?

sto/SYNACT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/SYNACT analysis?

The full report lives at /stocks/sto/SYNACT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/SYNACT?

The latest report frames sto/SYNACT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/SYNACT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.